EP2256135

CSL BEHRING GMBH
Application Number
EP10168453A
Filing Date
Jun 14, 2007
Status
Granted And Under Opposition
Feb 8, 2019
Grant Date
Mar 13, 2019
External Links
Slate, Register

Biblio Summary

The patent EP2256135B1 was granted on Mar 13, 2019 by Csl Behring Gmbh The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOVERATIV THERAPEUTICS, INC./SWEDISH ORPHAN BIOVITRUM AB (PUBL)Dec 13, 2019WITHDRAWN

The table below shows the patents of Csl Behring Gmbh that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3564267Proteolytically Cleavable Fusion Proteins With High Molar Specific ActivityMar 17, 20212